$IBM

Thomas Robert David sold $5.8M of IBM

Thomas Robert David (Senior Vice President) sold 25,000 shares of INTERNATIONAL BUSINESS MACHINES CORP (IBM) at $230.32 ($5.76M total) on 2026-08-26.

Original reporting
SEC EDGAR · Thomas Robert David
Published Aug 28, 2026, 8:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 8:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IBM
Bearish
medium confidence
Mentioned
$IBM
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IBMBearishLow
01

Why it matters

The disclosed sale provides fresh data on insider sentiment, which can be factored into short-term trading models.

02

Market read

The filing is a primary disclosure of a material insider sale, offering a modest trading signal for IBM.

03

What to watch

Potential upcoming corporate actions (e.g., dividend, buyback) that could offset the negative signal.

Relevance 6/10Novelty 7/10Timing: post-market 2026-08-26

Background

Form 4 filings disclose insider transactions and are considered primary sources of new information.

Company-level read

Ticker impact

$IBMBearishMedium confidence
Context

Senior Vice President Thomas Robert David sold 25,000 IBM shares for $5.76M on 2026-08-26, reducing his stake to 47,800 shares.

Expected impact

Possible short-term downward pressure on IBM stock, but limited impact given the size relative to market cap.

Evidence & confidence

A $5.8M sale by a senior officer is material enough to attract attention, yet IBM's large float dilutes the effect.

Market effects

Minimal impact on the broader technology sector; insider sales are common and not sector-defining.

No significant regional effect; IBM trades primarily on US exchanges.

Limited global relevance; only investors tracking IBM may adjust positions.

Counterpoint

The sale could be unrelated to confidence and merely a personal financial decision, so it may not warrant a sell stance.

Key entities

  • Thomas Robert David

    Senior Vice President at IBM, reporting officer in the filing.

  • IBM

    International Business Machines Corporation, ticker IBM.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MSFTMed

Sars to pay Microsoft and IBM R2.75-billion in sole-source deals

South African Revenue Service (Sars) awarded Microsoft and IBM contracts worth R2.75 billion for software, hardware, and support services over three years, approved without open tenders. Microsoft's deal is valued at R1.58 billion, while IBM's is R1.17 billion. Sars also deployed AI tools, including Microsoft Copilot, and reported handling millions of digital queries. Sars faces underfunding risks and is exploring alternative funding models for modernization.

$IBMMed

Wall Street analyst sets IBM stock price for 12 months

Truist Securities analyst Arvind Ramnani initiated a 'Hold' rating for IBM (NYSE: IBM) with a 12-month price target of $240, implying a 6.37% upside from its current price of $225.63. The bullish outlook is based on IBM's strong positioning in key domains, but risks include operational execution and AI infrastructure adoption timelines. TipRanks reports an average price target of $250.45 from 20 analysts, suggesting an 11% potential uptick.

$IBMMed

IBM and SAP Team Up to Support Cloud ERP Modernization for Mid-Sized Enterprises, Offering End-to-End AI Infrastructure Development

IBM and SAP launched 'IBM Ready for SAP Solutions' to aid mid-sized firms in cloud ERP migration, combining SAP's platform with IBM's consulting. Early adopters reported efficiency gains. IBM aims to capitalize on SAP's 2027 maintenance deadline, despite recent financial struggles. IBM's stock is down 25% YTD, with analysts divided on its outlook.

$IBMHighAI 8/10

Truist starts IBM at Hold, says AI demand timing is the key question

Truist initiated coverage of IBM with a Hold rating and $240 price target, citing long-term potential in enterprise computing but near-term execution risks. IBM's Q2 miss was attributed to timing and budget shifts, leading to a 20% stock drop. Software revenue grew 8%, but deferred contracts impacted guidance. Analysts see upside potential if deferred deals close and software growth improves.